Beilei Xu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Beilei Xu has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Shiqi Ling
Department of Dermatology Dermatology Hospital, Southern Medical University Guangzhou China
3 shared publications - Wei Li
Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, China
3 shared publications - Xiaochun Liu
Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, China
3 shared publications - Xu Yao
Department of Allergy and Rheumatology, Jiangsu Provincial Key Laboratory of Dermatology, Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College, Nanjing 210042, China
3 shared publications - Yang Luo
Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, China
3 shared publications - Ao Wang
Department of Allergy and Rheumatology, Jiangsu Key Laboratory of Molecular Biology for Skin Diseases and STIs, Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing 210042, China
2 shared publications
Latest Publications
- Open Access
- 6 October 2026
- Published by Wiley in Pigment Cell & Melanoma Research
- Vol. 39 (6) , e70124
UVB ‐Induced Repigmentation in Vitiligo: Hair Follicle Melanocyte Stem Cell Migration and Its Molecular Mechanisms
Vitiligo is an acquired depigmentation disorder characterized by the loss of epidermal melanocytes and can markedly impair patients' quality of life. Because of its dual effects on immunosuppression and repigmentation, UVB phototherapy has become a first‐line treatment for vitiligo. It is particularly valuable in inducing repigmentation of skin lesions. Since epidermal melanocytes are markedly reduced or even absent in vitiligo lesions, migration of melanocyte stem cells (McSCs) from the hair follicle bulge to the interfollicular epidermis is considered a critical step in UVB‐induced repigmentation, as it enables the replenishment of epidermal melanocytes. Therefore, this review summarizes the molecular mechanisms by which UVB induces McSC migration. Current evidence suggests that UVB primarily regulates McSC migration, proliferation, and differentiation indirectly by remodeling the McSC niche. In this process, keratinocytes, inflammatory cells, and other niche‐associated cells release multiple paracrine mediators, including SCF, EDN1, bFGF, PGE2, and WNT. These factors coordinately regulate the physiological activities of McSCs. In addition, we propose that changes in the expression of melanocyte surface receptors may be an important limiting factor governing the migratory response of McSCs. This review also discusses the molecular markers of McSCs and the physiological changes that accompany their migration. Based on current evidence, we further hypothesize that some melanocytes migrating to the epidermis may retain the ability to dedifferentiate and return to the hair follicle. This process may represent an important mechanism by which UVB‐induced McSC migration does not deplete the McSC reservoir.
- 6 October 2026
- Published by Wiley in Pigment Cell & Melanoma Research
- Vol. 39 (6) , e70124
Open AccessUVB ‐Induced Repigmentation in Vitiligo: Hair Follicle Melanocyte Stem Cell Migration and Its Molecular Mechanisms
Vitiligo is an acquired depigmentation disorder characterized by the loss of epidermal melanocytes and can markedly impair patients' quality of life. Because of its dual effects on immunosuppression and repigmentation, UVB phototherapy has become a first‐line treatment for vitiligo. It is particularly valuable in inducing repigmentation of skin lesions. Since epidermal melanocytes are markedly reduced or even absent in vitiligo lesions, migration of melanocyte stem cells (McSCs) from the hair follicle bulge to the interfollicular epidermis is considered a critical step in UVB‐induced repigmentation, as it enables the replenishment of epidermal melanocytes. Therefore, this review summarizes the molecular mechanisms by which UVB induces McSC migration. Current evidence suggests that UVB primarily regulates McSC migration, proliferation, and differentiation indirectly by remodeling the McSC niche. In this process, keratinocytes, inflammatory cells, and other niche‐associated cells release multiple paracrine mediators, including SCF, EDN1, bFGF, PGE2, and WNT. These factors coordinately regulate the physiological activities of McSCs. In addition, we propose that changes in the expression of melanocyte surface receptors may be an important limiting factor governing the migratory response of McSCs. This review also discusses the molecular markers of McSCs and the physiological changes that accompany their migration. Based on current evidence, we further hypothesize that some melanocytes migrating to the epidermis may retain the ability to dedifferentiate and return to the hair follicle. This process may represent an important mechanism by which UVB‐induced McSC migration does not deplete the McSC reservoir.
- Open Access
- 19 December 2023
- Published by Elsevier in Cell Reports Medicine
- Vol. 4 (12) , 101340
Attenuation of allergen-specific immunotherapy for atopic dermatitis by ectopic colonization of Brevundimonas vesicularis in the intestine
- 19 December 2023
- Published by Elsevier in Cell Reports Medicine
- Vol. 4 (12) , 101340
Open AccessAttenuation of allergen-specific immunotherapy for atopic dermatitis by ectopic colonization of Brevundimonas vesicularis in the intestine
- 8 May 2022
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 142 (11) , 2968-2977.e10
Transglutaminase 3 Attenuates Skin Inflammation in Psoriasis by Inhibiting NF-κB Activation through Phosphorylated STAT3–TET3 Signaling
- 8 May 2022
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 142 (11) , 2968-2977.e10
Transglutaminase 3 Attenuates Skin Inflammation in Psoriasis by Inhibiting NF-κB Activation through Phosphorylated STAT3–TET3 Signaling
- 1 February 2020
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 140 (2) , 370-379.e8
Transglutaminase 3 Promotes Skin Inflammation in Atopic Dermatitis by Activating Monocyte-Derived Dendritic Cells via DC-SIGN
- 1 February 2020
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 140 (2) , 370-379.e8
Transglutaminase 3 Promotes Skin Inflammation in Atopic Dermatitis by Activating Monocyte-Derived Dendritic Cells via DC-SIGN